product summary
company name :
Hycult Biotech
product type :
antibody
product name :
Thrombomodulin, Human, mAb RTM96
catalog :
HM2146
quantity :
100 µg
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
RTM96
reactivity :
human
application :
western blot, flow cytometry
more info or order :
citations: 2
Reference
Bergt S, Güter A, Grub A, Wagner N, Beltschany C, Langner S, et al. Impact of Toll-like receptor 2 deficiency on survival and neurological function after cardiac arrest: a murine model of cardiopulmonary resuscitation. PLoS ONE. 2013;8:e74944 pubmed publisher
French A, Evans C, Agniel D, Cohen M, Peters M, Landay A, et al. Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus. J Infect Dis. 2013;208:679-89 pubmed publisher
product information
Catalog no :
HM2146
Title :
Thrombomodulin, Human, mAb RTM96
Clone no :
RTM96
Quantity :
100 µg
Application code :
flow cytometry,functional studies,western blot
Species :
human
Host species :
rat
Isotype :
IgG2a
Conjugate :
purified
Aliases :
Thrombomodulin
Type :
mAb
Antigen :
CD141
Meta data :
CD141
more info or order :
company information
Hycult Biotech
Frontstraat 2a
5405 PB UDEN
support@hycultbiotech.com
www.hycultbiotech.com
31 0 413 25 13 35
headquarters: Netherlands
Hycult Biotech develops, produces and markets antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields, with an emphasis on complement, neutrophil proteins, TLR, scavenger receptors and acute phase proteins. Furthermore, we have a strong interest in progressing research in the area of inflammation and cell damage caused by pathogens or oxidation factors.

Hycult Biotech’s mission and strategy is to advance insight in innate immunity related diseases, for the benefit of individuals and their quality of life.

As a leader within focused fields of immunology and cell biology, we develop products for the life sciences and in accordance with our mission it is our ambition to facilitate the transition of these products from research use into diagnostic testing. Many of our reagents are developed in close cooperation with scientists worldwide. Hycult Biotech has built a strong network with over 40 close scientific collaborations with leading international research institutes. We contribute to numerous projects and as a result, can continuously offer early access to an expanding range of innovative reagents. Hycult Biotech has been ISO-9001 certified since 1998 and we upgraded our certification to ISO-13485 in 2007, with a milestone of our first release of CE marked assays in 2009. Our vision, knowledgeable team and quality management system guarantee products of the highest grade combined with excellent technical service.